(Q43498259)

24 November 2017

title

Preclinical studies of a specific PPARγ modulator in the control of skin inflammation (English)

1 reference

24 November 2017

0 references

5

1 reference

24 November 2017

7

1 reference

24 November 2017

Emanuela Bastonini

4

0 references

Arianna Mastrofrancesco

Arianna Mastrofrancesco

1

0 references

Daniela Kovacs

Daniela Kovacs

2

0 references

Philippe Chavatte

Philippe Chavatte

8

0 references

Mauro Picardo

Mauro Picardo

11

0 references

Pierre Desreumaux

Pierre Desreumaux

9

0 references

author name string

Massimiliano Sarra

3

1 reference

24 November 2017

Nicaela Aspite

6

1 reference

24 November 2017

Giovanni Monteleone

10

1 reference

24 November 2017

language of work or name

English

0 references

publication date

28 October 2013

1 reference

Journal of Investigative Dermatology

24 November 2017

published in

1 reference

24 November 2017

volume

134

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

1001-1011

1 reference

Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone

24 November 2017

cites work

1 reference

12 December 2020

Topical application of PPARα (but not β/δ or γ) suppresses atopic dermatitis in NC/Nga mice

1 reference

12 December 2020

Medium Chain Fatty Acids Are Selective Peroxisome Proliferator Activated Receptor (PPAR) γ Activators and Pan-PPAR Partial Agonists

1 reference

12 December 2020

PPARs at the crossroads of lipid signaling and inflammation

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise

1 reference

12 December 2020

Epidermal signal transduction and transcription factor activation in activated keratinocytes.

1 reference

12 December 2020

Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis

1 reference

12 December 2020

Elements controlling the expression and induction of the skin hyperproliferation-associated keratin K6.

1 reference

12 December 2020

The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells

1 reference

12 December 2020

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

12 December 2020

2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-γ activation

1 reference

12 December 2020

Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis

1 reference

12 December 2020

TNF-α downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-α antagonists to improve skin barrier.

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease

1 reference

12 December 2020

Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation

1 reference

12 December 2020

Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing

1 reference

12 December 2020

Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.

1 reference

12 December 2020

Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes

1 reference

12 December 2020

Pathogenesis and therapy of psoriasis

1 reference

12 December 2020

Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-gamma, normalizes epidermal homeostasis in a murine hyperproliferative disease model

1 reference

12 December 2020

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

1 reference

12 December 2020

Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases

1 reference

12 December 2020

Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation.

1 reference

12 December 2020

Selective modulation of promoter recruitment and transcriptional activity of PPARgamma

1 reference

12 December 2020

The role of nuclear factor-kappa B in cytokine gene regulation

1 reference

12 December 2020

Thiazolidinediones and PPARγ agonists: time for a reassessment

1 reference

12 December 2020

Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation

1 reference

12 December 2020

PPAR gamma and human metabolic disease

1 reference

12 December 2020

Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators

1 reference

12 December 2020

Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation

1 reference

12 December 2020

Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation

1 reference

12 December 2020

Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study

1 reference

12 December 2020

PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis

1 reference

12 December 2020

Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study

1 reference

12 December 2020

Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase

1 reference

12 December 2020

Psoriasis and metabolic syndrome: is peroxisome proliferator-activated receptor-γ part of the missing link?

1 reference

12 December 2020

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

Pituitary tumor transforming gene 1 induces tumor necrosis factor-α production from keratinocytes: implication for involvement in the pathophysiology of psoriasis

1 reference

12 December 2020

Nuclear receptors versus inflammation: mechanisms of transrepression

1 reference

12 December 2020

IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia

1 reference

12 December 2020

Psoriasis: emerging therapeutic strategies

1 reference

12 December 2020

Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases

1 reference

12 December 2020

Renal and vascular mechanisms of thiazolidinedione-induced fluid retention

1 reference

12 December 2020

1 reference

12 December 2020

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

12 December 2020

Suppression of macrophage inflammatory responses by PPARs

1 reference

12 December 2020

Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation

1 reference

12 December 2020

BP-1107 [{2-[4-(2,4-dioxo-thiazolidin-5-ylmethyl)-phenoxy]-ethyl}-methyl-amide]: a novel synthetic thiazolidinedione that inhibits epidermal hyperplasia in psoriatic skin-severe-combined immunodeficient mouse transplants after topical application

1 reference

12 December 2020

Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

1 reference

12 December 2020

Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6).

1 reference

12 December 2020

N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo

1 reference

12 December 2020

Peroxisome proliferator-activated receptors in inflammation control

1 reference

12 December 2020

Identifiers

DOI

10.1038/JID.2013.448

1 reference

24 November 2017

1 reference